| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |